Surface Oncology, Inc. Made Headway

Thu 21 May 20 at 05:30 PM
Surface Oncology, Inc. Made Headway

Surface Oncology, Inc. (SURF:NASDAQ) shot up at $5.95, representing a gain of 53.4%. On Wed 20 May 20, SURF:NASDAQ hit a New 2-Week High of $3.88. The stock appeared on our News Catalysts scanner on Wed 20 May 20 at 08:08 AM in the 'MERGER' category. From Wed 06 May 20, the stock recorded 50.00% Up Days and 54.55% Green Days

About Surface Oncology, Inc. (SURF:NASDAQ)

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses.